TransMedics (TMDX) EBITDA Margin (2018 - 2026)

TransMedics (TMDX) recorded quarterly EBITDA Margin of 7.64% in Q1 2026, down 42.23% quarter-over-quarter from 13.23% in Q4 2025, and down 1147.0% on a YoY basis from 0.73% in Q1 2025.

TransMedics (TMDX) EBITDA Margin (2018 - 2026) Analysis & Trends

TransMedics' EBITDA Margin history runs 9 years deep, the most recent figure standing at 7.64% for Q1 2026.

  • In Q1 2026, EBITDA Margin fell 1147.0% year-over-year to 7.64%; the TTM figure through Mar 2026 stood at 14.85% (up 409.0% YoY), while the FY2025 annual figure was 17.93%, up 944.0% from the prior year.
  • EBITDA Margin was 7.64% for Q1 2026 at TransMedics, down from 13.23% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 23.24% in Q2 2025 to a low of 59.0% in Q1 2022.
  • Historically, EBITDA Margin has averaged 4.82% across 5 years, with a median of 3.61% in 2024.
  • The sharpest annual moves came in 2022 and 2023: EBITDA Margin soared 19502 bps in 2022, then plunged 2107 bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 21.61% in 2022, then jumped by 115 bps to 3.21% in 2023, then soared by 122 bps to 7.11% in 2024, then soared by 86 bps to 13.23% in 2025, then slumped by 42 bps to 7.64% in 2026.
  • The last three EBITDA Margin figures came in at 7.64% (Q1 2026), 13.23% (Q4 2025), and 16.2% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 TransMedics 2.72 Bn 2.26 Bn 101.16 Mn 7.64%

Historic Data

Download Data
DateValue
Mar 31, 2026 7.64%
Dec 31, 2025 13.23%
Sep 30, 2025 16.20%
Jun 30, 2025 23.24%
Mar 31, 2025 19.12%
Dec 31, 2024 7.11%
Sep 30, 2024 3.61%
Jun 30, 2024 10.94%
Mar 31, 2024 12.82%
Dec 31, 2023 3.21%
Sep 30, 2023 -42.65%
Jun 30, 2023 -1.73%
Mar 31, 2023 -5.03%
Dec 31, 2022 -21.61%
Sep 30, 2022 -21.59%
Jun 30, 2022 -47.49%
Mar 31, 2022 -59.00%
Dec 31, 2021 -117.17%
Sep 30, 2021 -216.61%
Jun 30, 2021 -113.86%